Tackling antimicrobial resistance in Low and Middle-Income Countries (LMICs)

GCRF Funding Cycle2018-19 Principal InvestigatorDr Wilber Sabiiti SchoolsMedicine ODA countriesMalawi, Mozambique, Uganda, Tanzania, Gabon, South Africa, Kenya, Ghana, Moldova, Thailand, Vietnam Sustainable Development GoalsGoal 3 Tuberculosis (TB) is a poverty related disease and over 90% of the deaths occurs in Low and Medium Income Low- and Medium-Income Countries. It is difficult disease to treat, taking … Read more

Scottish innovation to ensure safe and effective TB treatment in Africa

GCRF Funding Cycle2018-19 Principal InvestigatorDerek Sloan SchoolsMedicine, Geography and Sustainable Development ODA countriesUganda Sustainable Development GoalsGoal 3 Tuberculosis (TB), the leading infectious cause of death worldwide, is a major public health problem in Uganda with 86,000 new cases (40% HIV co-infected) and 11,000 deaths per year. Recent clinical trial results suggest that higher doses of … Read more

Implementation and evaluation of interprofessional ‘Arclight’ ophthalmoscopy training for health care students at the University of Rwanda

GCRF Funding Cycle2018-19 Principal InvestigatorDr Andrew Blaikie SchoolsMedicine ODA countriesRwanda Sustainable Development GoalsGoal 3 The World Health Organisation (WHO) highlights that interprofessional education (IPE) is required to prepare a ‘practice-ready’ collaborative health workforce to manage the challenges of global health issues. Preventable and treatable visual impairment is a global health issue that affects 285 million … Read more

Evaluation of a portable light source for photodynamic therapy of cutaneous leishmaniasis

GCRF Funding Cycle2018-19 Principal InvestigatorProfessor Ifor Samuel SchoolsPhysics & Astronomy ODA countriesBrazil, Ethiopia Sustainable Development GoalsGoal 3, Goal 16 Leishmaniasis is among the six most important tropical diseases in terms of its impact in public health and affects 12 million people around the world. It is very debilitating, especially cutaneous leishmaniasis, as it can lead … Read more